• Monday, Sep 28, 2020
  • Last Update : 01:32 am

Indonesia starts human trials of China-made virus vaccine

  • Published at 06:55 pm August 11th, 2020
Indonesia starts human trials of China-made virus vaccine
Nurse Isabelli Guasso administers China's Sinovac vaccine, a potential vaccine for the coronavirus disease (COVID-19), to volunteer and nurse Fabiana Souza, at the Sao Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS), in Porto Alegre, Brazil August 8, 2020 Reuters

Bangladesh is also likely to allow the Phase 3 trial of Sinovac’s vaccine

Indonesia on Tuesday launched human trials of a Chinese-made coronavirus vaccine with some 1,600 volunteers slated to take part in the six-month study.

The vaccine candidate, produced by Sinovac Biotech, is among just a few in the world to enter Phase 3 clinical trials, or large-scale testing on humans -- the last step before regulatory approval.

The treatment, known as CoronaVac, is already being tested on 9,000 health workers in Brazil, the second-hardest-hit country in the coronavirus pandemic after the United States.

Bangladesh is also likely to allow the Phase 3 trial of Sinovac’s vaccine.

Bangladesh Medical Research Council approved the vaccine in the middle of July more than a month after the icddr,b, local partner of Sinovac, submitted an application to the Directorate General of Drug Administration (DGDA) for a clinical trial of the vaccine.

"We will study the application for the trial of the Sinovac's vaccine and will let the icddr,b know the decision at the appropriate time," Health Secretary Abdul Mannan told journalists after a meeting with icddr,b scientists at the ministry on August 4.

Indonesia, the world's fourth most populous country, has been struggling to contain its mounting virus cases, with more than 127,000 confirmed infections and over 5,700 deaths.

But the true scale of the public health crisis is believed to be much bigger, given the Southeast Asian nation's low testing rates.

The governor of Indonesia's most populous province, West Java, was among 1,620 volunteers slated to take part in clinical testing, which was set to wrap up in February.

If the vaccine proves safe and effective, Indonesian officials said, there were plans to produce up to 250 million doses for the sprawling archipelago of nearly 270 million, although they gave few details of the tentative roll-out.

On Tuesday, Indonesia's President Joko Widodo toured a factory in Bandung city, operated by state-owned pharmaceutical firm Bio Farma, where production would begin.

"Once again I want to highlight that the Covid-19 threat will not end until all people in Indonesia are vaccinated," Widodo said ahead of the tour.

63
63
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail